risperidone and Dwarfism
risperidone has been researched along with Dwarfism in 1 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Dwarfism: A genetic or pathological condition that is characterized by short stature and undersize. Abnormal skeletal growth usually results in an adult who is significantly below the average height.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|---|---|
| "She also exhibited precocious puberty and growth hormone deficiency and required treatment for improving final height." | 1.40 | Endocrinological anomalies in a patient with 12q14 microdeletion syndrome. Completing phenotype of this exceptional short stature condition. ( Marco, FC; Nso-Roca, AP; Ricote, JM; Ruiz, MJ, 2014) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Nso-Roca, AP | 1 |
| Marco, FC | 1 |
| Ricote, JM | 1 |
| Ruiz, MJ | 1 |
Other Studies
1 other study available for risperidone and Dwarfism
| Article | Year |
|---|---|
Endocrinological anomalies in a patient with 12q14 microdeletion syndrome. Completing phenotype of this exceptional short stature condition.
Topics: Antipsychotic Agents; Body Height; Child; Child Behavior Disorders; Chromosome Deletion; Dwarfism; E | 2014 |